Bayer invested US$15 million in its Veracruz plant to expand production of the active ingredient needed to produce Yasmin brand contraceptives.

The inauguration of a new module for the production of Active Pharmaceutical Ingredients (API's) is part of the 60th anniversary of this plant, where the company produces the active ingredients, based on hormones, necessary to produce contraceptives.

See also: San Luis Potosí projects greater dynamism as a result of new investments in the automotive sector

From here, the company will send the powdered active substance to its plant in Germany, where the final processing of birth control pills takes place.

Manuel Bravo, president and CEO of Bayer in Mexico, said that this plant is part of the company's global supply chain.

"Bayer has a network of intermediate asset plants, three of which are in Germany, one in Spain and the one in Veracruz, which is the only one in America," he says.

The executive explained that Bayer has invested about US$42 million in this plant, an amount that includes this latest expansion, which will generate about 60 new jobs.

Of interest: Logistics companies continue to be the engine of industrial demand in Mexico City

This plant, which the company acquired in 2007, also produces ampoules, pre-filled syringes, suppositories, suppositories, and tablets used in hormonal, antifungal, and anti-inflammatory treatments.

The executive reiterated that by 2025 the company will invest US$395 million in Mexico, of which 15% will go to the Orizaba plant, in addition to doubling production at its biological plant in Tlaxcala, as well as at the Lerma plant. where he manufactures over-the-counter drugs such as aspirin.

In Solili you can consult industrial warehouses available in Chihuahua and Reynosa

Original note